Pathophysiology of AIDS Associated PML
艾滋病相关 PML 的病理生理学
基本信息
- 批准号:6529689
- 负责人:
- 金额:$ 26.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-08-15 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Polyomavirus hominis 2 brain comorbidity cytokine disease /disorder etiology disease /disorder proneness /risk gene expression genetic regulation genetic regulatory element hamsters host organism interaction human immunodeficiency virus human tissue immunocytochemistry molecular pathology oligodendroglia postmortem progressive multifocal leukoencephalopathy protein structure function tissue /cell culture transcription factor transforming growth factors tumor necrosis factor alpha virus infection mechanism virus protein
项目摘要
DESCRIPTION: (Provided by applicant) PML is a subacute, fatal demyelinating
disease of the Central Nervous System (CNS) that affects individuals with
underlying defects in immunity. This once considered rare disease is more
frequently seen after the AIDS pandemic. The significantly higher incidence of
PML in patients with AIDS than in any other immunosuppressive condition
suggests that there may be an interaction between HIV-1 and JC Virus. Previous
in vitro studies have demonstrated direct intercommunication between HIV-1 and
JCV through the HIV-1 encoded regulatory protein Tat. This interaction may also
be mediated by cytokines and transcription factors. Although there is no strong
evidence for the infection of oligodendrocytes by HIV- 1, it is postulated that
soluble Tat released from the HIV-l infected cells in the CNS such as
microglia, can be taken up by the neighboring uninfected cells, including
oligodendrocytes harboring the opportunistic JCV. Activation of JCV could also
be mediated indirectly through enhanced expression and release of cytokines
such as TNF-alpha and TGF-beta from the HIV-1 infected cells. TNF-alpha can
induce expression and activity of inducible transcription factors, such as NFkB
which increases expression of the JCV genome, via the KB motif positioned in
the viral promoter region. On the other hand, TGF-beta, through the SMAD
pathway, could also lead to activation and elevated expression of the JCV
genome. With this notion, we hypothesize that activation of JCV by Tat could be
mediated by localization of Tat in the nucleus of JCV infected
oligodendrocytes, and indirectly by altering expression of cytokines, which
leads to enhanced activity of NFKB subunits p50 and p65, and TGF-beta /SMAD in
the JCV infected oligodendrocytes.
We will perform cell culture studies to investigate the regulatory pathways,
including TNF-a and TGF-beta that upregulate JCV replication and we will also
carry out immunohistochemical studies in human AIDS and non- AIDS related PML
autopsy specimens to illustrate replication of JCV in oligodendrocytes at the
level of NFKB and SMADs, as well as Tat in cells which are infected with JCV.
The results from these experiments will provide information to elucidate the
role of HIV-1 and its transactivator protein Tat in the activation of JC Virus,
through direct and/or indirect mechanisms, and therefore in the development of
PML in patients with AIDS.
描述:(由申请方提供)PML是一种亚急性、致死性脱髓鞘
中枢神经系统(CNS)疾病,影响个体,
免疫力的潜在缺陷。这种曾经被认为是罕见的疾病,
在艾滋病大流行后经常出现。高得多的发病率
PML在艾滋病患者中比在任何其他免疫抑制条件下
提示HIV-1与JC病毒之间可能存在相互作用。先前
体外研究表明,HIV-1和
JCV通过HIV-1编码的调节蛋白达特。这种相互作用还可以
由细胞因子和转录因子介导。虽然没有强大的
HIV- 1感染少突胶质细胞的证据,推测
从CNS中的HIV-1感染细胞释放的可溶性达特,
小胶质细胞可以被邻近的未感染细胞吸收,包括
少突胶质细胞携带机会性JCV。JCV的激活也可以
通过增强细胞因子的表达和释放间接介导
如来自HIV-1感染细胞的TNF-α和TGF-β。TNF-α可以
诱导型转录因子如NF κ B表达和活性
其通过定位于细胞中的KB基序增加JCV基因组的表达,
病毒启动子区域。另一方面,TGF-β通过SMAD
通路,也可能导致JCV的激活和表达升高
基因组基于这一概念,我们假设达特激活JCV可能是
由达特在感染JCV的细胞核中的定位介导
少突胶质细胞,并间接通过改变细胞因子的表达,
导致NF κ B亚单位p50和p65以及TGF-β/SMAD在细胞内的活性增强。
JCV感染少突胶质细胞。
我们将进行细胞培养研究,以调查调控途径,
包括上调JCV复制的TNF-α和TGF-β,
对人类艾滋病和非艾滋病相关的PML进行免疫组化研究
尸检标本,以说明JCV在少突胶质细胞中的复制,
NF κ B和SMAD的水平,以及用JCV感染的细胞中的达特。
这些实验的结果将提供信息来阐明
HIV-1及其反式激活蛋白达特在JC病毒活化中的作用,
通过直接和/或间接机制,
艾滋病患者的PML。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis Del Valle其他文献
Luis Del Valle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luis Del Valle', 18)}}的其他基金
Molecular Histopathology Analytical Microscopy Core (MHAM)
分子组织病理学分析显微镜核心 (MHAM)
- 批准号:
10223345 - 财政年份:2017
- 资助金额:
$ 26.34万 - 项目类别:
Molecular Histopathology and Analytical Microscopy Core
分子组织病理学和分析显微镜核心
- 批准号:
10664023 - 财政年份:2017
- 资助金额:
$ 26.34万 - 项目类别:
Involvement of Survivin in the Development of PML
Survivin 参与 PML 的发展
- 批准号:
7600589 - 财政年份:2007
- 资助金额:
$ 26.34万 - 项目类别:
Involvement of Survivin in the Development of PML
Survivin 参与 PML 的发展
- 批准号:
7388930 - 财政年份:2007
- 资助金额:
$ 26.34万 - 项目类别:
Involvement of Survivin in the Development of PML
Survivin 参与 PML 的发展
- 批准号:
7285346 - 财政年份:2007
- 资助金额:
$ 26.34万 - 项目类别:
Involvement of Survivin in the Development of PML
Survivin 参与 PML 的发展
- 批准号:
8042548 - 财政年份:2007
- 资助金额:
$ 26.34万 - 项目类别:
Involvement of Survivin in the Development of PML
Survivin 参与 PML 的发展
- 批准号:
8066552 - 财政年份:2007
- 资助金额:
$ 26.34万 - 项目类别: